AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Scope & Guideline
Advancing respiratory health through cutting-edge research.
Introduction
Aims and Scopes
- Respiratory Diseases:
The journal addresses a wide range of respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, and pulmonary hypertension, emphasizing both clinical and molecular research. - Critical Care Medicine:
The focus extends to critical care medicine, particularly the management of patients with acute respiratory distress syndrome (ARDS), sepsis, and other critical conditions, highlighting advancements in intensive care practices. - Molecular and Cellular Biology:
Research published in the journal often explores the underlying molecular and cellular mechanisms of lung diseases, including studies on gene expression, inflammation, and immune response. - Innovative Therapeutic Approaches:
The journal features studies on novel therapeutic strategies, including pharmacological interventions, biologics, and emerging therapies for various pulmonary conditions. - Public Health and Epidemiology:
The journal also emphasizes public health issues related to respiratory diseases, including studies on the impact of environmental factors, tobacco use, and healthcare disparities. - Patient-Centered Research:
There is a strong focus on patient-reported outcomes and quality of life, aiming to integrate patient perspectives into research and clinical care.
Trending and Emerging
- Personalized Medicine:
Emerging research focuses on tailoring treatments based on genetic, environmental, and lifestyle factors, particularly in conditions like asthma and pulmonary fibrosis, emphasizing the importance of individualized patient care. - Telemedicine and Remote Monitoring:
The COVID-19 pandemic has accelerated the adoption of telemedicine and remote patient monitoring technologies, leading to an increase in studies evaluating their effectiveness in managing chronic respiratory diseases. - Long-COVID and Post-Acute Sequelae:
There is growing attention on the long-term effects of COVID-19, including post-acute sequelae, with research exploring respiratory, cardiovascular, and neurological implications, highlighting the need for comprehensive care strategies. - Microbiome Research:
Increasing interest in the role of the lung microbiome in health and disease, particularly its impact on asthma, COPD, and pulmonary infections, is emerging as a significant area of research. - Innovations in Imaging Techniques:
Advancements in imaging technologies, such as machine learning applications in radiology and novel imaging biomarkers, are gaining prominence for their potential to enhance diagnosis and monitoring of lung diseases. - Environmental and Social Determinants of Health:
Research increasingly emphasizes the impact of environmental factors and social determinants on respiratory health, focusing on disparities and the need for community-based interventions.
Declining or Waning
- Traditional Diagnostic Methods:
There appears to be a decreasing emphasis on traditional diagnostic methods, such as bronchoscopies and lung biopsies, as newer, less invasive techniques and imaging modalities gain traction. - Basic Science without Clinical Correlation:
Research focusing solely on basic science without direct clinical implications or applications is becoming less prevalent, as there is a greater push for translational research that bridges laboratory findings to patient care. - General Pulmonary Rehabilitation:
While pulmonary rehabilitation remains important, there is a shift towards more specialized and targeted rehabilitation practices rather than general approaches, leading to a decline in studies focusing on broad rehabilitation protocols. - Conventional Pharmaceutical Approaches:
There is a noticeable reduction in studies promoting conventional pharmaceutical approaches, with more research being directed towards personalized medicine and biologic therapies. - Single Disease Focus:
Research that concentrates on single diseases, such as isolated studies on asthma or COPD without considering comorbidities, appears to be waning in favor of studies that examine the interplay between multiple conditions.
Similar Journals
Respiratory Care
Shaping the Landscape of Critical Care Medicine.Respiratory Care is a leading journal in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, published by DAEDALUS ENTERPRISES INC. With a history dating back to 1973 and continuing through 2024, this journal serves as a vital platform for disseminating innovative research findings, clinical practices, and advancements in respiratory healthcare. The journal is recognized for its impact, reflected in its impressive Q2 quartile rankings across several categories in 2023, demonstrating its relevance and influence in the medical community. Although it is not an Open Access publication, it provides critical insights and foster discussions aimed at enhancing patient care and treatment protocols for respiratory diseases. The journal is indexed in notable databases, ensuring wide visibility and accessibility of its content to researchers, professionals, and students dedicated to advancing knowledge and practice in respiratory care.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Elevating Knowledge in Molecular and Pulmonary SciencesThe AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, published by the esteemed American Thoracic Society, is a premier platform dedicated to advancing knowledge in the fields of pulmonary and respiratory medicine, cell biology, and clinical biochemistry. With an impressive impact factor and recognition as a Q1 journal in multiple categories for 2023, it ranks among the top tier of scholarly publications, evidencing its influence and contribution to the scientific community. Since its inception in 1989, the journal has provided a critical forum for researchers and professionals to disseminate innovative findings and pivotal reviews, driving forward the frontiers of respiratory biology. While the journal currently operates under traditional access mechanisms, it seeks to bridge gaps in research by presenting high-quality articles that address vital health challenges. As a key resource for both established researchers and emerging scholars in molecular biology and respiratory science, this journal plays a pivotal role in shaping the future of respiratory health advancements.
Lung India
Empowering knowledge for better lung care.Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.
EUROPEAN RESPIRATORY JOURNAL
Exploring Innovations in Respiratory ResearchThe EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.
EXPERIMENTAL LUNG RESEARCH
Elevating Knowledge in Pulmonary and Respiratory MedicineEXPERIMENTAL LUNG RESEARCH, published by Taylor & Francis Inc, is a pivotal journal within the field of pulmonary and respiratory medicine, with its extensive coverage spanning from 1980 to 2024. The journal is indexed with ISSN 0190-2148 and E-ISSN 1521-0499, marking its commitment to disseminating high-quality research. With its Category Quartile rankings falling within Q3 in Clinical Biochemistry, Molecular Biology, and Pulmonary and Respiratory Medicine as of 2023, EXPERIMENTAL LUNG RESEARCH serves as a crucial platform for researchers and professionals seeking to explore innovative findings and advancements in lung physiology, pathology, and therapeutic approaches. Although currently not Open Access, it offers substantial insights through rigorous peer-reviewed articles that contribute significantly to the scientific community's understanding of respiratory health. With Scopus rankings reflecting its relevance within its categories, this journal attracts a diverse readership interested in advancing the field of lung research.
CHEST
Exploring the frontiers of cardiology and pulmonary medicine.CHEST is a premier journal published by Elsevier, focusing on the vital fields of cardiology, critical care, and pulmonary medicine. Established in 1970, this esteemed journal has continually provided authoritative research, reviews, and clinical studies, catering to a global audience of healthcare professionals, researchers, and students. With an impressive impact factor, CHEST ranks in the top quartile (Q1) across its core categories according to the latest Scopus metrics, securing its position as a leading resource within cardiology (Rank #16), pulmonary (Rank #9), and critical care (Rank #8). Published quarterly, it offers a wealth of knowledge essential for advancing understanding and improving patient outcomes in these critical areas of healthcare. Researchers and practitioners are encouraged to submit their work, contributing to the ongoing discourse that shapes innovative practices and policies in respiratory and cardiovascular health.
Annals of Thoracic Medicine
Unveiling new horizons in cardiology and surgery.Annals of Thoracic Medicine is a prominent open-access journal, published by Wolters Kluwer Medknow Publications, focusing on the critical fields of cardiology, pulmonary and respiratory medicine, and surgery. With an ISSN of 1817-1737 and an E-ISSN of 1998-3557, this journal aims to disseminate cutting-edge research, clinical findings, and innovative practices that can significantly impact the health outcomes of patients dealing with thoracic diseases. Since its inception in 2006, it has established itself as a reputable source of knowledge, achieving Q2 quartile rankings in 2023 across its main categories. Currently ranked #126 in Medicine & Surgery and exhibiting a growing SCOPUS percentile, the journal plays an essential role in advancing the understanding and treatment of thoracic conditions. Open access options ensure that research is readily available to a global audience, facilitating collaboration and knowledge sharing among researchers, healthcare professionals, and students in the field.
Canadian Journal of Respiratory Critical Care and Sleep Medicine
Exploring innovative solutions for better patient outcomes.Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.
Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine
Exploring the Frontiers of Cardiology and PulmonologyClinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.
Annals of the American Thoracic Society
Exploring new frontiers in pulmonary health and clinical excellence.Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.